T1D Research Update

I am a huge supporter of JDRF, and with that being said, lots of people ask me what kinds of developments in t1d research have been made. Well, a lot of times I do not have a clear answer to that.

Today, I got this email from JDRF explaining exactly where all of the money raised has gone to. There is hope for an easier life for me and all of those living with Type 1 diabetes. Life is becoming easier and less difficult to manage. I just wanted to share these updates for those who have supported my team and my efforts in raising money for JDRF.

Dear Calla,

Every July, JDRF sets ambitious goals for progress in type 1 diabetes (T1D) research in the coming year because you, our supporters, inspire us to aim higher. Thank you. Your generosity makes our strategic plan possible and propels us toward our shared vision of a world without T1D.

Because of members of the JDRF family like you, we can report real progress in T1D research that will impact millions of people living with the disease. Together, we can celebrate achievements you helped make possible this past year such as:

  1. Beta cell encapsulation therapy that can create insulin independence for up to two years is moving to human safety testing.
  2. Current studies show potential in a drug that can slow or stop kidney disease, a serious complication of T1D.
  3. At-home testing of artificial pancreas systems that will maintain tighter blood-glucose control automatically has begun.

These are just a few of the significant milestones you helped us reach this year. You can learn more about all of our top advances when you click here.

Although we all take well-deserved pride in these life-changing accomplishments, we can’t stop until we have reached our ultimate goal of a world where nobody has to fear developing T1D. When you make a gift to JDRF, the leading global organization funding T1D research, you impact the lives of millions of children, adults, and families challenged by the disease.

Thank you for your commitment to improving the lives of all people living with T1D until we end this serious disease. Inspired by your trust in our plan, JDRF is turning Type One into Type None.


Derek Rapp
JDRF President and CEO